End-of-Dose Wearing Off Parkinson's Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
End-of-Dose Wearing Off Parkinson's Medications, Costs & Savings
Pharmacist insight
Anti-seizure medications require careful monitoring of blood levels to ensure therapeutic effectiveness. I advise patients never to switch between brand and generic without consulting their pharmacist, as even small differences in absorption can affect seizure control. Medication adherence is the single most important factor.
Angela C. Beverly, PharmD
About End-of-Dose Wearing Off Parkinson's
End-of-dose wearing off, often simply called 'wearing off,' is a common motor complication experienced by many people with Parkinson's disease, particularly as the condition progresses. It occurs when the effects of levodopa, the most effective medication for Parkinson's motor symptoms, begin to diminish before the next scheduled dose. This leads to the re-emergence of symptoms like tremor, rigidity, slowness of movement (bradykinesia), and difficulty walking. It’s a sign that the brain's ability to store dopamine is decreasing, making the body more reliant on the precise timing and absorption of each levodopa dose.
Managing wearing off often involves adjusting the timing and dosage of levodopa, taking smaller doses more frequently, or adding other medications. These adjunctive therapies can include MAO-B inhibitors (like rasagiline or selegiline) to prolong dopamine's effect,
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.